Gross Margin
4.85%vs Specialty Chemicals peers Updated Sep 22, 2026Profit Margin
-1.88%vs Specialty Chemicals peers Updated Sep 22, 2026Operating Margin
-3.24%vs Specialty Chemicals peers Updated Sep 22, 2026Return on Assets (TTM)
-0.06%vs Specialty Chemicals peers Updated Sep 22, 2026Return on Equity (TTM)
-3.45%vs Specialty Chemicals peers Updated Sep 22, 2026Revenue (TTM)
3.63BCNY541.48M · vs all stocks (USD) Updated Sep 22, 2026Revenue per Share (TTM)
4.54CNYUpdated Sep 22, 2026Quarterly Revenue Growth
-33.40%vs Specialty Chemicals peers Updated Sep 22, 2026Gross Profit (TTM)
221.65MCNY33.10M · vs all stocks (USD) Updated Sep 22, 2026EBITDA (TTM)
307.39MCNY45.90M · vs all stocks (USD) Updated Sep 22, 2026Net Income (TTM)
-68.05MCNY-10.16M · vs all stocks (USD) Updated Sep 22, 2026Quarterly Earnings Growth (YoY)
4.36%vs Specialty Chemicals peers Updated Sep 22, 2026Operating Cash Flow (TTM)
-128.53MCNY-19.19M · vs all stocks (USD) Updated Sep 22, 2026Levered Free Cash Flow (TTM)
-208.59MCNY-31.15M · vs all stocks (USD) Updated Sep 22, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Sep 22, 2026Minority Interest (Equity)
15.61MCNYFY2025 · Dec 31, 2025Revenue
3.92BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
3.63BCNYFY2025 · Dec 31, 2025Gross Profit
289.99MCNYFY2025 · Dec 31, 2025Operating Income
92.04MCNY13.74M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-22.03MCNYFY2025 · Dec 31, 2025Income Tax Expense
-13.83MCNYFY2025 · Dec 31, 2025Net Income
-8.20MCNYFY2025 · Dec 31, 2025EBIT
81.52MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
307.39MCNYFY2025 · Dec 31, 2025Research & Development
126.63MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
25.05MCNYFY2025 · Dec 31, 2025Other Operating Expenses
16.90MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
2.34MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
103.54MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0100CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
798.56MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
798.56MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-8.20MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
211.30KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-638.96MCNYFY2025 · Dec 31, 2025Free Cash Flow
-988.63MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
235.86MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-8.20MCNYFY2025 · Dec 31, 2025Other Non-cash Items
104.53MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-537.82MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-197.47MCNYFY2025 · Dec 31, 2025Capital Expenditures
-349.67MCNYFY2025 · Dec 31, 2025Net Acquisitions
-130.13MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-479.80MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.77BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.89BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-92.96MCNYFY2025 · Dec 31, 2025Other Financing Charges
-105.12MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
677.55MCNYFY2025 · Dec 31, 2025